Company / Revenue
Bioventus Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$568.1M
FY2025
5-year range
$340.1M / $573.3M
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 5 years, ranging from $340M in FY2021 to $573M in FY2024.
Based on SEC 10-K filings.
$568M in FY2025 with a 3-year CAGR of +3.5%.
Improved from $431M to $568M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.5%, indicating consistent growth.
- In FY2025, revenue decreased 0.9% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $568.1M | -0.9% |
| FY2024 | $573.3M | +33.0% |
| FY2023 | $430.9M | -15.9% |
| FY2022 | $512.1M | +50.6% |
| FY2021 | $340.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026